Shaping priorities in genetic medicine.
D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis; D003695:Delivery of Health Care; D003933:Diagnosis; D004467:Economics; D005069:Evaluation Studies as Topic; D035082:Federal Government; D005380:Financing, Government; D005817:Genetic Counseling; D030342:Genetic Diseases, Inborn; D005818:Genetic Engineering; D024861:Genetic Enhancement; D020022:Genetic Predisposition to Disease; D033142:Genetic Services; D005820:Genetic Testing; D015316:Genetic Therapy; D006076:Government; D017408:Guidelines as Topic; D015276:Health Care Rationing; D006801:Humans; D007231:Infant, Newborn; D007349:Insurance, Health, Reimbursement; D007603:Jurisprudence; D008403:Mass Screening; D010344:Patient Advocacy; D018579:Patient Selection; D019989:Persons with Intellectual Disabilities; D010661:Phenylketonurias; D019836:Preimplantation Diagnosis; D011287:Prejudice; D011296:Prenatal Diagnosis; D011640:Public Policy; D027724:Reproductive Techniques, Assisted; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D013219:State Government; D009626:Terminology as Topic; D014481:United States; D000509:alpha-Fetoproteins
Genetics and Reproduction; Health Care and Public Health